Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Adct save search
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.68%
H: 11.71%
C: 6.08%
zynlonta trial therapeutics
ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
research therapeutics
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.93%
grants therapeutics
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2.06 billion between 2022 and 2027, Technavio
Published: 2024-03-26 (Crawled : 04:00) - prnewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.0%
H: 8.1%
C: 3.57%
therapeutics market
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -3.82%
H: 2.57%
C: -8.88%
business year therapeutics financial results
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.21%
H: 5.61%
C: 3.95%
therapeutics
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024
Published: 2024-03-06 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.21%
H: 5.61%
C: 3.95%
conference therapeutics financial results
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.21%
H: 5.61%
C: 3.95%
association presentation cancer research meeting therapeutics
ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 3.5%
H: 0.0%
C: -5.83%
conference health care therapeutics
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
Published: 2024-01-10 (Crawled : 12:00) - globenewswire.com
ELYM | $3.7 -1.33% -1.35% 110K
|
|
| O: -2.88%
H: 1.7%
C: 1.7%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 2.42%
H: 4.72%
C: 2.83%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: -2.63%
H: 6.61%
C: 1.95%
therapeutics
ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
Published: 2024-01-04 (Crawled : 12:30) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -7.23%
H: 26.62%
C: 22.08%
therapeutics
ADC Therapeutics Provides Business Updates
Published: 2024-01-04 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -7.23%
H: 26.62%
C: 22.08%
business therapeutics
ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evaluating ZYNLONTA® in Combination with Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Published: 2023-12-12 (Crawled : 10:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 1.0%
H: 2.97%
C: 1.98%
zynlonta trial therapeutics results
ADC Therapeutics Receives NYSE Notice of Non-Compliance With Continued Listing Standards
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -6.89%
H: 0.0%
C: -9.74%
therapeutics
ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -6.89%
H: 0.0%
C: -9.74%
business therapeutics financial results
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 2.4%
H: 5.35%
C: 5.35%
conference therapeutics
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
Published: 2023-11-02 (Crawled : 14:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
presentation meeting therapeutics
ADC Therapeutics to Host Third Quarter 2023 Financial Results Conference Call on November 7, 2023
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.48%
H: 6.8%
C: 1.46%
conference therapeutics financial results
ADC Therapeutics to Participate in September Investor Conferences
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.38%
therapeutics
ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023)
Published: 2023-08-30 (Crawled : 00:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 3.33%
H: 1.61%
C: -3.23%
zynlonta meeting trial therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.